in Short

Algeria : Merck and LDM sign agreement to produce medications locally

Merck and the LDM Group have signed a memorandum of understanding to produce levothyroxine-based medications in Algeria. Production will begin in 2026, marking a step towards pharmaceutical self-sufficiency and demonstrating Merck’s commitment to local production.

Articles similaires

Laisser un commentaire

Bouton retour en haut de la page